2.81 USD
-0.02 (-0.71%)
2.77 USD
-0.04 (-1.42%)
ChartMill assigns a Buy % Consensus number of 84% to CNTB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.78. This target is 176.78% above the current price.
CNTB was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about CNTB.
In the previous month the buy percentage consensus was at a similar level.
CNTB was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-13 | BTIG | Reiterate | Buy -> Buy |
| 2025-10-31 | BTIG | Initiate | Buy |
| 2025-08-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-17 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-04 | HC Wainwright & Co. | Initiate | Buy |
| 2023-09-13 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-02-08 | SVB Leerink | Maintains | Outperform |
| 2022-06-02 | Cantor Fitzgerald | Initiate | Overweight |
| 2022-05-05 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2022-05-04 | SVB Leerink | Maintains | Outperform |
| 2022-01-06 | SVB Leerink | Maintains | Outperform |
| 2021-07-02 | CICC | Initiate | Outperform |
| 2021-04-13 | SVB Leerink | Initiate | Outperform |
| 2021-04-13 | Jefferies | Initiate | Buy |
CONNECT BIOPHARMA HOLDINGS L / CNTB FAQ
What do analysts expect the price target to be for CONNECT BIOPHARMA HOLDINGS L (CNTB)?
9 analysts have analysed CNTB and the average price target is 7.78 USD. This implies a price increase of 176.78% is expected in the next year compared to the current price of 2.81.
What is the consensus rating for CONNECT BIOPHARMA HOLDINGS L (CNTB) stock?
The consensus rating for CONNECT BIOPHARMA HOLDINGS L (CNTB) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.